RAM Core is now accepting early access applications from institutional desks.

DEAL INTELLIGENCE FOR INVESTMENT BANKS AND PRIVATE EQUITY

The first draft arrives already sourced.

RAM Core reads every document the firm holds on a name, drafts the tearsheet or the buyer list, cites every figure to its page — and declares plainly what it could not find.

Book Demo
RECONCILEDRAM CORE · MERIDIAN CORPUS
Where did MedVista’s enterprise value land?
MedVista — Restated Exit CIMp.12 · valuation
MedVista — Valuation ModelDCF output tab
MER-2024-MEDV-11deal record
Enterprise value · 2 figures on file
$95MCANONICALRestated Exit CIM · p.12
$86MSUPERSEDEDValuation Model · pre-restatement
WONSale to Nimbus Healthcare · Mar 2025 · 11.5× EBITDA
3 SOURCES · 1.4sMER-2024-MEDV-11

The last three deals in a sector live in the model, the CIM and someone’s inbox — not in one place.

Analysts rebuild the tearsheet from scratch because nobody trusts the last one.

A client goes quiet for fourteen months and nobody notices until the mandate goes elsewhere.

Ask the record

Pick a question. RAM Core reads the firm’s own documents, drafts the answer, cites every figure to its page — and declares plainly what it could not find.

Live output · Meridian demo corpus

ANSWERED
RAM CORE · MERIDIAN CORPUS · 276 DOCS
What's our history with MedVista Diagnostics?
11 DOCUMENTS · FULL COVERAGE

Two mandates on file. We ran MedVista's strategic sale to Nimbus Healthcare, closed Mar 2025 at $95M — an 11.5× exit. No contact since.

Enterprise value
$95M1
EV / EBITDA
11.5×2
Outcome
Won · Mar 20253
Last interaction
Mar 20253
Relationship status · at risk
MedVista has been cooling for 16 months. The firm won them a $95M sale and has not spoken to them since. Two mandates, eleven documents, no follow-up.
Sources
1MedVista — Restated Exit CIM p.12 · valuation summary
2MedVista — Valuation Model DCF output tab
3MER-2024-MEDV-11 · deal record close event
18 DOCUMENTS · FULL COVERAGE

Tearsheet drafted. Every field below traces to a document and a page. Nothing is inferred.

Enterprise value
$128M1
Revenue · FY24
$48M2
EV / EBITDA
9.2×1
Status
Platform Acq. — Live3
Sources
1HeliosWorks — Restated Exit CIM p.8 · headline metrics
2HeliosWorks — Management Accounts FY24 revenue schedule
3MER-2026-HELO-19 · deal record stage: live
4 REGULATORY EVENTS ON FILE

MedVista carried four regulatory events. The one that cost time was a six-week clearance delay, followed by a condition imposed at approval.

Filings
21
Clearance delay
6 weeks1
Conditions imposed
11
Deal still closed
Won · 11.5×2
Carry this into HeliosWorks
HeliosWorks is live now, targeting Q3 2026, with 1 filing already logged. The diagnostics precedent says: build six weeks of clearance slack into the timetable.
Sources
1MedVista — Regulatory File filings + clearance correspondence
2MER-2024-MEDV-11 · deal record close event
2 DOCUMENTS · INSUFFICIENT FOR THIS FIELD

RAM Core will not answer this.

Field intentionally omitted
5-year revenue CAGR — no corroborating source found in the corpus.

The firm holds two documents on BlueWave Aqua: a relationship ledger and pricing notes from April 2026. Neither contains a five-year revenue history. RAM Core could estimate one. It will not — an unsourced figure in a tearsheet is worse than a gap in a tearsheet.
Historical deal value
$180M1
Active mandates
31
Last interaction
Apr 2026 · pricing2
5-yr revenue CAGR
— omitted
Sources
1BlueWave — Relationship Ledger mandate rollup
2BlueWave — Pricing Discussion Notes Apr 2026 · EML
3 SOURCES · 1.4sANSWERS ONLY FROM THE FIRM’S OWN RECORD

ENTITY GRAPH · RELATIONSHIP BOARD · MERIDIAN CORPUS

The record, drawn.

Nine years of deals. Every relationship the firm has, and every one it has let go cold.

EntitySectorMandatesDocsLast touchStatus
Vantage DiagnosticsHealthcare Diagnostics3418 dayswarming
HeliosWorks AutomationIndustrial Automation2182 dayswarming
Auriga Capital PartnersFinancial Services21421 dayssteady
Cascade Freight SystemsLogistics & Freight2934 dayscooling
MedVista DiagnosticsHealthcare Diagnostics211Mar 2025at risk
Harbor Point LogisticsLogistics & Freight15Sep 2024at risk

MedVista paid for a $95M sale in March 2025. Nobody has spoken to them since. The record knew. Nobody asked it.

SUPERSEDE LOGIC · MERIDIAN CORPUS

Mgmt EV modelEV $86M · pre-restatementQ1 lender packageEV $95MSponsor deckEV $95MCONFLICT · 2 FIGURES ON FILE$95MCANONICAL$86MSUPERSEDED

Three documents. Two figures. One answer — with the losing number shown, not hidden.

ADVISORY

Built with guidance from senior practitioners at Morgan Stanley and Barclays.

Active advisors on product direction, IB workflow design, and institutional fit.

Morgan StanleyBarclays
Private deployment. Your data never trains any model. SOC 2 Type II in progress.

See YODA AI run a live deal.

Thirty minutes. A real IB task from your coverage area. Memory surfacing prior context.

Book Demo